There are 398 resources available
7P - Development and Validation of a Deep Learning RNA Modification Model Predict Disease-free Survival in Patients with Breast Cancer
Presenter: Yunfang Yu
Session: Poster Display session
8P - An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy.
Presenter: Celine Blaye
Session: Poster Display session
9P - Long term recurrence risk predictions by CanAssist Breast in a sub-cohort of TEAM trial
Presenter: Manjiri Bakre
Session: Poster Display session
10P - Survival according to early ctDNA dynamics in advanced breast cancer (ABC) treated with endocrine therapy (ET) and a CDK4/6 inhibitor (CDK4/6i)
Presenter: Olga Martinez Saez
Session: Poster Display session
11P - Real-world analysis of Oncotype DX Recurrence Score (ODX RS) indications and impact on adjuvant chemotherapy (CT) decisions: experience from the French LISE cohort
Presenter: Caroline Charles
Session: Poster Display session
12P - Prevalence of functional and genomic homologous recombination deficiency (HRD) in germline RAD51C/D patients
Presenter: Alba Llop-Guevara
Session: Poster Display session
13P - Clinicopathological and Prognostic Significance of Tertiary Lymphoid Structures in Breast Cancer: A Systemic Review and Meta-Analysis
Presenter: Bin Wang
Session: Poster Display session
14P - Gut and oral microbiota profiling in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC) receiving pembrolizumab (P) plus eribulin (E): CALADRIO
Presenter: Nancy Teng
Session: Poster Display session
15P - Integration of whole genome data with machine learning technology in breast cancer subtyping
Presenter: Weronika Majer-Burman
Session: Poster Display session
16P - Assessing early changes in plasma HER2 levels is useful for predicting therapeutic response in advanced breast cancer: A multicenter, prospective, noninterventional clinical study
Presenter: Yi-Kun Kang
Session: Poster Display session